Emergent BioSolutions | EBS - 무역 채무자





무역 채무자 변화 날짜
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 407.63M 73.6M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amarin USD 126.83M 477K 2025-12
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Exelixis USD 328.95M 42.03M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Lonza CHF 1.78B 55M 2025-12
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Pacira USD 125.64M 1.57M 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Xoma USD 14.78M 4.96M 2024-06